Patient management system by Intel-GE JV gets US nod
This article was originally published in Clinica
Intel Health Guide Express, a patient care management system developed by Intel-GE Care Innovations, has received 510(k) clearance from the US FDA. Intel-GE Care Innovations a joint venture between GE and Intel which became operational in January (www.clinica.co.uk, 5 January 2011), intends to start selling the system in the US in the second quarter of 2011. At the patient's end, it runs on standard consumer PCs or the Intel Health Guide PHS6000; the physician uses the Intel Health Care Management Suite, an online interface that allows clinicians to monitor patients and remotely manage chronic care. The in-home patient device can connect to devices including blood pressure monitors, glucose meters, pulse oximeters, peak flow meters and weight scales.
You may also be interested in...
Dr Noam Emanuel is the founder and chief technology officer of Ness Ziona, Israel-based drug delivery firm PolyPid. The 15-strong firm, established in 2008, has developed an encapsulation technology which allows the precise targeting of drug release.
Mesoblast has received the all-clear from the US FDA to start a Phase III clinical trial for bone marrow regeneration in patients with blood cancers. The study will be conducted together with Mesoblast's strategic alliance partner, Cephalon, which will fund the trial.
Mesoblast has received the green light from the US FDA to begin a Phase II trial of its proprietary adult mesenchymal precursor cell (MPC) product for the treatment of degenerative disc disease, a major cause of chronic low back pain.